AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Freedman, RR Girgis, R Mayes, MD
Citation: Rr. Freedman et al., Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma, J RHEUMATOL, 28(1), 2001, pp. 119-121

Authors: Girgis, R Abrams, SA Castracane, VD Gunn, SK Ellis, KJ Copeland, KC
Citation: R. Girgis et al., Ethnic differences in androgens, IGF-I and body fat in healthy prepubertalgirls, J PED END M, 13(5), 2000, pp. 497-503

Authors: teNyenhuis, E Girgis, R
Citation: E. Tenyenhuis et R. Girgis, Effect of slitting electrical core steel on measured iron loss, J MAGN MAGN, 215, 2000, pp. 110-111

Authors: Freedman, RR Girgis, R
Citation: Rr. Freedman et R. Girgis, Effects of menstrual cycle and race on peripheral vascular alpha-adrenergic responsiveness, HYPERTENSIO, 35(3), 2000, pp. 795-799

Authors: Badesch, DB Tapson, VF McGoon, MD Brundage, BH Rubin, LJ Wigley, FM Rich, S Barst, RJ Barrett, PS Kral, KM Jobsis, MM Loyd, JE Murali, S Frost, A Girgis, R Bourge, RC Ralph, DD Elliott, CG Hill, NS Langleben, D Schilz, RJ McLaughlin, VV Robbins, IM Groves, BM Shapiro, S Medsger, TA Gaine, SP Horn, E Decker, JC Knobil, K
Citation: Db. Badesch et al., Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial, ANN INT MED, 132(6), 2000, pp. 425

Authors: Freedman, RR Girgis, R Mayes, MD
Citation: Rr. Freedman et al., Endothelial and adrenergic dysfunction in Raynaud's phenomenon and scleroderma, J RHEUMATOL, 26(11), 1999, pp. 2386-2388

Authors: Freedman, RR Girgis, R Mayes, MD
Citation: Rr. Freedman et al., Acute effect of nitric oxide on Raynaud's phenomenon in scleroderma, LANCET, 354(9180), 1999, pp. 739-739

Authors: Tirdel, GB Girgis, R Fishman, RS Theodore, J
Citation: Gb. Tirdel et al., Metabolic myopathy as a cause of the exercise limitation in lung transplant recipients, J HEART LUN, 17(12), 1998, pp. 1231-1237
Risultati: 1-8 |